Physical exercise in diabetes mellitus type 2 - Metabolic basis and evidence-based recommendations;Bewegungstherapie bei diabetes mellitus typ II - Metabolische grundlagen und evidenzbasierte empfehlungen

Deutsche Zeitschrift fur Sportmedizin

Volumn 57, Issue 10, 2006, Pages 242-247

  Konig D ^a   Deibert, P ^a   Dickhuth, H H ^a   Berg, A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Aerobic exercise; Cardiovascular fitness; Diabetes mellitus; Evidence based medicin; Strength training

Indexed keywords

EID: 33845448716     PISSN: 03445925     EISSN: 03445925     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Anonymous: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853.
2. Avramoglu RK, Basciano H, Adeli K: Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 368 (2006) 1-19.
3. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Haring HU, Jacob S: Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50 (2001) 2579-2584.
4. Berg A, König D: Aspekte zur Prävention und Therapie von Fettstoffwechselstörungen unter besonderer Berücksichtigung des metabolischen Syndroms. Deut Z Sportmed 56 (2005) 74-82.
5. Berggren JR, Hulver MW, Houmard JA: Fat as an endocrine organ: influence of exercise. J Appl Physiol 99 (2005) 757-764.
6. Bergman RN, Mittelman SD: Central role of the adipocyte in insulin resistance. J Physiol Pharmacol 9 (1998) 205-221.
7. Boden G: Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Ass Am Phys 111 (1999) 241-248.
8. Boden G, Lebed B, Schatz M, Homko C, Lemieux S: Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50 (2001) 1612-1617.
9. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. J Am Med Ass 286 (2001) 1218-1227.
10. Boule NG, Kenny GP, Haddad E, Wells GA, Sigal RJ: Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetol 46 (2003) 1071-1081.
11. Brechtel K, Dahl DB, Machann J, Bachmann OP, Wenzel I, Maier T, Claussen CD, Haring HU, Jacob S, Schick F: Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med. 45 (2001) 179-183.
12. Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, Hawley JA: Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88 (2003) 5444-5451.
13. Bruce CR, Carey AL, Hawley JA,Febbraio MA: Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52 (2003) 2338-2345.
14. Bruce CR, Hawley JA: Improvements in insulin resistance with aerobic exercise training: a lipocentric approach. Med Sci Sports Exerc 36 (2004) 1196-1201.
15. Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry JD: Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50 (2001) 123-130.
16. Ferrara CM, McCrone SH, Brendle D, Ryan AS, Goldberg AP: Metabolic effects of the addition of resistive to aerobic exercise in older men. Int J Sport Nutr Exerc Metab 14 (2004) 73-80.
17. Frayn KN: Adipose tissue as a buffer for daily lipid flux. Diabetol 45 (2002) 1201-1210.
18. Honkola A, Forsen T, Eriksson J: Resistance training improves the metabolic profile in individuals with type 2 diabetes. Acta Diabetol 34 (1997) 245-248.
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 (1996) 1-12.
20. Jessen N, Goodyear LJ: Contraction signaling to glucose transport in skeletal muscle. J Appl Physiol 99 (2005) 330-337.
21. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng J Med 346 (2002) 393-403.
22. König D, Deibert P, Dickhuth HH, Berg A: Körperliche Aktivität und Dyslipoproteinämie. MMW Fortschr Med 146 (2004) 34-37.
23. Machann J, Haring H, Schick F, Stumvoll M: Intramyocellular lipids and insulin resistance. Diabetes Obes Metab 6 (2004) 239-248.
24. Mensink GB: Körperliche Aktivität. Gesundheitswesen 61 (1999) S126-S131.
25. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. J Am Med Ass 286 (2001) 1195-1200.
26. Perseghin G: Muscle lipid metabolism in the metabolic syndrome. Cur Op Lipidol 16 (2005) 416-420.
27. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L: Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48 (1999) 1600-1606.
28. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Eng J Med 350 (2004) 664-671.
29. Ravussin E, Smith SR: Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 967 (2002) 363-378.
30. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I: Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 133 (2000) 92-103.
31. Shulman GI: Cellular mechanisms of insulin resistance in humans. Am J Cardiol 84 (1999) 3J-10J.
32. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C: Physical activity/exercise and type 2 diabetes. Diab Care 27 (2004) 2518-2539.
33. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 344 (2001) 1343-1350.
34. van Loon LJ: Use of intramuscular triacylglycerol as a substrate source during exercise in humans. J Appl Physiol 97 (2004) 1170-1187.
35. van Loon LJ, Goodpaster BH: Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Eur J Physiol 451 (2006) 606-616.
36. van Loon LJ, Koopman R, Manders R, van der WW, van Kranenburg GP, Keizer HA: Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab 287 (2004) E558-E565.
37. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S: Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362 (2003) 951-957.
38. Yki-Jarvinen H: Fat in the liver and insulin resistance. Ann Med 37 (2005) 347-356.